logo

For the Inventor, By the Inventor

Woodbridge, CT, United States of America

Alan C Sartorelli

USPTO Granted Patents = 14

Average Co-Inventor Count = 2.7

ph-index = 5

Forward Citations = 60(Granted Patents)


Company Filing History:

goldMedal14 out of 1,327 
 
Yale University
 patents
silverMedal1 out of 17 
 
Vion Pharmaceuticals, Inc.
 patents
where one patent can have more than one assignee

Years Active: 1987-2005

Loading Chart...
14 patents (USPTO):Explore Patents
1. 6960568 - Nucleosides and related processes, pharmaceutical compositions and methods (2005-11-01),
2. 6911460 - Antiviral agents and methods of treating viral infections (2005-06-28),
3. 6040338 - N,n-bis(sulfonyl)hydrazines useful as antineoplastic agents (2000-03-21),
4. 5721259 - Method of using 2-formylpyridine thiosemicarbazone compounds (1998-02-24),
5. 5637619 - Antitumor 2-aminocarbonyl-1, (1997-06-10),
6. 5281715 - 2-formylpyridine thiosemicarbazone compounds (1994-01-25),
7. 5256820 - 1-alkyl-2-acyl-1,2-disulfonylhydrazines (1993-10-26),
8. 5214068 - Sulfonylhydrazines and their use as antineoplastic agents and as (1993-05-25),
9. 5101072 - Sulfonylhydrazines and their use as antineoplastic agents and as (1992-03-31),
10. 4962114 - 1-alkyl-1-sulfonyl-2-alkoxycarbonylsulfenylhydrazines having (1990-10-09),
11. 4892887 - N,N'-bis(sulfonyl)hydrazines having antineoplastic activity (1990-01-09),
12. 4849563 - Novel 1-alkyl-1-arenesulfonyl-2-alkoxycarbonylsulfenylhydrazines having (1989-07-18),
13. 4806531 - 2,3-bis(aziridinyl)-1,4-naphthoquinone sulfonate derivatives having (1989-02-21),
14. 4684747 - N,N'-bis(sulfonyl)hydrazines having antineoplastic activity (1987-08-04),

Title: Alan C Sartorelli: Innovator in Pharmaceutical Chemistry

Introduction

Alan C Sartorelli is a distinguished inventor based in Woodbridge, Connecticut, known for his significant contributions to pharmaceutical chemistry. With a total of 14 patents to his name, Sartorelli has made remarkable advancements in the field of antiviral and anticancer therapies.

Latest Patents

Sartorelli's latest patents include innovative nucleosides and related processes, as well as pharmaceutical compositions and methods. These novel nucleosides are designed for a wide range of applications, including antiviral, antineoplastic, and antibacterial treatments. Notable embodiments of his inventions feature halogen-substituted analogues of 3-deazaadenosine and 3-deazaguanosine. His compounds, such as 4-Amino-6-fluoro-1-(β-D-ribofuranosyl)imidazo[4,5-c]pyridine and 6-Amino-7-bromo-1,5-dihydro-1-β-D-ribofuranosylimidazo[4,5-c]pyridin-4-one, have demonstrated potent antiviral and anticancer activity in vitro. Additionally, he has developed methods for treating viral or fungal infections using specific thiosemicarbazones and their prodrug forms.

Career Highlights

Throughout his career, Sartorelli has worked with prestigious institutions, including Yale University and Vion Pharmaceuticals, Inc. His work has significantly impacted the development of new therapeutic agents, showcasing his expertise in pharmaceutical innovation.

Collaborations

Sartorelli has collaborated with notable colleagues, including Krishnamurthy Shyam and Philip G Penketh, further enhancing the scope and impact of his research.

Conclusion

Alan C Sartorelli's contributions to pharmaceutical chemistry through his innovative patents and collaborations have positioned him as a key figure in the development of new antiviral and anticancer therapies. His work continues to influence the field and offers hope for improved treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…